Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arbitrum (ARB) vs Immunefi (IMU) Price & Performance

Arbitrum
Immunefi

Price performance

Price movement over the last 24 hours

Key statistics

Arbitrum vs Immunefi — how do they compare? Arbitrum trades at Rp1,376 (market cap Rp8,76T, Rp1,08T 24h volume), while Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume). The key difference: Arbitrum is far larger — about 324084.4× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Arbitrum's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Arbitrum for 61 Days and Immunefi for 5 Days on average.

ARBIMU
Market Cap
Rp8,76TRp27,03M
Volume (24h)
Rp1,08TRp39,91M
Circulating Supply
6,4B ARB873,4M / 10B IMU (9%)
Typical Hold Time
61 Days5 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Arbitrum

Arbitrum is trading at Rp1,371 with a bearish technical signal, as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits below the pivot point of Rp1,402, with immediate support at Rp1,354. Recent ecosystem news includes Pheasant Network's $2 million seed round to advance AI-powered cross-chain technology, potentially benefiting Arbitrum's DeFi ecosystem.

Overall outlook is cautious due to bearish technicals, but network growth and AI integration developments offer long-term opportunities. Key risks include high volatility, regulatory uncertainty, and reliance on Ethereum's ecosystem. Investors should monitor support levels and on-chain activity for signs of trend reversal.

Immunefi

Immunefi token shows limited market activity with a modest market cap of Rp27,03M and low circulation rate of 9%. The asset demonstrates minimal trading volume and network engagement, with token holders maintaining short 5-day holding periods. Recent coverage appears misaligned with the cryptocurrency's actual blockchain metrics, suggesting potential entity confusion.

Outlook remains cautious due to low liquidity and limited ecosystem development. Key opportunities include potential network growth, while major risks involve low adoption, regulatory uncertainty, and market volatility. Investors should monitor on-chain metrics for signs of genuine protocol activity.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ARB
88% Buy12% Sell
Avg holding period · 61 Days
IMU

No sentiment data available yet.

About Arbitrum

Arbitrum is an Ethereum layer-2 scaling solution. It uses optimistic rollups to achieve its goal of improving speed, scalability and cost-efficiency on Ethereum. Arbitrum benefits from the security and compatibility of Ethereum. Another benefit is the higher throughput and lower fees compared to Ethereum. That is made possible thanks to moving most of the computation and storage load off-chain. Arbitrum’s native token is called ARB and is used for governance. Offchain Labs, the developers behind Arbitrum, announced the shift to a decentralized autonomous organization (DAO) structure — the Arbitrum DAO. ARB holders can vote on proposals that affect the features, protocol upgrades, funds allocation and election of a Security Council.

Read more on ARB

About Immunefi

Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.

Read more on IMU